74 related articles for article (PubMed ID: 8876780)
1. Potential prevention strategies for Alzheimer disease.
Thal LJ
Alzheimer Dis Assoc Disord; 1996; 10 Suppl 1():6-8. PubMed ID: 8876780
[TBL] [Abstract][Full Text] [Related]
2. Designing a large prevention trial: statistical issues.
Kryscio RJ; Mendiondo MS; Schmitt FA; Markesbery WR
Stat Med; 2004 Jan; 23(2):285-96. PubMed ID: 14716729
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study.
Yip AG; Green RC; Huyck M; Cupples LA; Farrer LA;
BMC Geriatr; 2005 Jan; 5():2. PubMed ID: 15647106
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. The impact of prevention on reducing the burden of cardiovascular disease.
Kahn R; Robertson RM; Smith R; Eddy D
Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant strategies for Alzheimer's disease.
Grundman M; Grundman M; Delaney P
Proc Nutr Soc; 2002 May; 61(2):191-202. PubMed ID: 12133201
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying therapies for Alzheimer disease: challenges to early intervention.
Cummings JL; Doody R; Clark C
Neurology; 2007 Oct; 69(16):1622-34. PubMed ID: 17938373
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
9. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
10. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
11. Current pharmacotherapies for Alzheimer's disease.
Knopman DS
Geriatrics; 1998 Sep; 53 Suppl 1():S31-4. PubMed ID: 9745634
[TBL] [Abstract][Full Text] [Related]
12. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Alzheimer's disease.
Gauthier S
Ann Med Interne (Paris); 1998 Jun; 149(4):228-30. PubMed ID: 11490550
[TBL] [Abstract][Full Text] [Related]
14. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
15. Chronic disease long-term drug prevention trials: lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).
Meinert CL; Breitner JC
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S7-S14. PubMed ID: 18632005
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition.
Steele M; Stuchbury G; Münch G
Exp Gerontol; 2007; 42(1-2):28-36. PubMed ID: 16839733
[TBL] [Abstract][Full Text] [Related]
18. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.
Fillenbaum GG; Kuchibhatla MN; Hanlon JT; Artz MB; Pieper CF; Schmader KE; Dysken MW; Gray SL
Ann Pharmacother; 2005 Dec; 39(12):2009-14. PubMed ID: 16227448
[TBL] [Abstract][Full Text] [Related]
19. Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.
Candore G; Balistreri CR; Grimaldi MP; Vasto S; Listì F; Chiappelli M; Licastro F; Lio D; Caruso C
Ann N Y Acad Sci; 2006 Nov; 1089():472-86. PubMed ID: 17261790
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
